Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 3/2018

30.11.2017 | Review

Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

verfasst von: Jürgen C. Becker, Andreas Stang, Axel zur Hausen, Nicole Fischer, James A. DeCaprio, Richard W. Tothill, Rikke Lyngaa, Ulla Kring Hansen, Cathrin Ritter, Paul Nghiem, Christopher K. Bichakjian, Selma Ugurel, David Schrama

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Merkel cell carcinoma (MCC) is a highly aggressive, often lethal neuroendocrine cancer. Its carcinogenesis may be either caused by the clonal integration of the Merkel cell polyomavirus into the host genome or by UV-induced mutations. Notably, virally-encoded oncoproteins and UV-induced mutations affect comparable signaling pathways such as RB restriction of cell cycle progression or p53 inactivation. Despite its low incidence, MCC recently received much attention based on its exquisite immunogenicity and the resulting major success of immune modulating therapies. Here, we summarize current knowledge on epidemiology, biology and therapy of MCC as conclusion of the project ‘Immune Modulating strategies for treatment of Merkel Cell Carcinoma’, which was funded over a 5-year period by the European Commission to investigate innovative immunotherapies for MCC.
Literatur
9.
Zurück zum Zitat Paulson KG, Tegeder A, Willmes C et al (2014) Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res 2(11):1071–1079CrossRefPubMedPubMedCentral Paulson KG, Tegeder A, Willmes C et al (2014) Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res 2(11):1071–1079CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Knight LM, Stakaityte G, Wood JJ et al (2015) Merkel cell polyomavirus small T antigen mediates microtubule destabilisation to promote cell motility and migration. J Virol 89(1):35–47CrossRefPubMed Knight LM, Stakaityte G, Wood JJ et al (2015) Merkel cell polyomavirus small T antigen mediates microtubule destabilisation to promote cell motility and migration. J Virol 89(1):35–47CrossRefPubMed
Metadaten
Titel
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
verfasst von
Jürgen C. Becker
Andreas Stang
Axel zur Hausen
Nicole Fischer
James A. DeCaprio
Richard W. Tothill
Rikke Lyngaa
Ulla Kring Hansen
Cathrin Ritter
Paul Nghiem
Christopher K. Bichakjian
Selma Ugurel
David Schrama
Publikationsdatum
30.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 3/2018
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-017-2099-3

Weitere Artikel der Ausgabe 3/2018

Cancer Immunology, Immunotherapy 3/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.